Abstract
To date, little is known about the duration and effectiveness of immunity as well as possible adverse late effects after an infection with SARS-CoV-2. Thus it is unclear, when and if liver transplantation can be safely offered to patients who suffered from COVID-19. Here, we report on a successful liver transplantation shortly after convalescence from COVID-19 with subsequent partial seroreversion as well as recurrence and prolonged shedding of viral RNA.
| Dokumententyp: | Zeitschriftenartikel |
|---|---|
| Fakultät: | Medizin |
| Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
| ISSN: | 1600-6135 |
| Sprache: | Englisch |
| Dokumenten ID: | 86621 |
| Datum der Veröffentlichung auf Open Access LMU: | 25. Jan. 2022 09:20 |
| Letzte Änderungen: | 25. Jan. 2022 09:20 |
